Acnomel Vanishing Topical and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Acnomel Vanishing Topical and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: resorcinol / sulfur topical
Brand name:
Synonyms: Acnomel Skin Tone (Topical)
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Acnomel Vanishing Topical-Insulin glargine, recombinant Subcutaneous
- Acnomel Vanishing Topical-Insulin glulisine
- Acnomel Vanishing Topical-Insulin Glulisine (Cartridges and Pens)
- Acnomel Vanishing Topical-Insulin Glulisine (Vials)
- Acnomel Vanishing Topical-Insulin glulisine Subcutaneous
- Acnomel Vanishing Topical-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Acrivastine and pseudoephedrine
- Insulin glargine and lixisenatide Subcutaneous-Actamin
- Insulin glargine and lixisenatide Subcutaneous-Actamin Maximum Strength
- Insulin glargine and lixisenatide Subcutaneous-Actemra
- Insulin glargine and lixisenatide Subcutaneous-Actemra (Tocilizumab (Intravenous))
- Insulin glargine and lixisenatide Subcutaneous-Actemra (Tocilizumab Auto-Injectors)